Last reviewed · How we verify
Sclersing liqiud of Lauromacrogol — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Sclersing liqiud of Lauromacrogol (Sclersing liqiud of Lauromacrogol) — Xinhua Hospital, Shanghai Jiao Tong University School of Medicine.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Sclersing liqiud of Lauromacrogol TARGET | Sclersing liqiud of Lauromacrogol | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Sclersing liqiud of Lauromacrogol CI watch — RSS
- Sclersing liqiud of Lauromacrogol CI watch — Atom
- Sclersing liqiud of Lauromacrogol CI watch — JSON
- Sclersing liqiud of Lauromacrogol alone — RSS
Cite this brief
Drug Landscape (2026). Sclersing liqiud of Lauromacrogol — Competitive Intelligence Brief. https://druglandscape.com/ci/sclersing-liqiud-of-lauromacrogol. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab